Work

A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx387.011

Authors: R.L. Jones, J.-Y. Blay, A. Lecesne, J. Martin-Broto, M.J. Pontes, J.M. Fernandez Santos, B. García San Andrés, G. Wang, S. Wang, C.R. Shin, R. Maki, S. Patel, G.D.S. Demetri

Institutions: Institute of Cancer Research, Royal Marsden Hospital, Centre Léon Bérard, Institut Gustave Roussy, Hospital Universitario Virgen del Rocío, PharmaMar (Spain), Janssen Research & Development (United States), Janssen (United States), Janssen Scientific Affairs (United States), The University of Texas MD Anderson Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2762341222

FWCI:

Cites:

Cited by: 1

Related to: 10